Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.
Important note: Information in this article was accurate in 1998. The state of the art may have changed since the publication date.
Reuters NewMedia, Inc.; Thursday August 20, 1998
"The present investigation reveals the encouraging findings that condom use intention among women undergoing sterilization appears to be on the rise, that sterilized women at most risk of contracting STDs are significantly more likely than others to plan to use condoms, and only some women will experience an increased risk for exposure to disease as a result of selecting this permanent method of contraception," conclude Drs. Haleh Sangi-Haghpeykar and Alfred N. Poindexter III.
The study, published in the August issue of Sexually Transmitted Diseases, looked at factors associated with condom use among 2,782 women undergoing surgical tubal sterilization between 1991 and 1996.
Results showed that women who were younger, black, unmarried, and did not have a steady partner were more likely to say they planned to use condoms following surgery.
Women who had used condoms for disease prevention in the past, had a previous STD, lacked partner involvement in the decision to undergo sterilization or had a higher number of previous sexual partners were also more likely to report planned condom use.
Hispanic and married women were less likely to say they planned to use condoms following sterilization.
The authors note that their study may be the first to report on an increase of condom use among sterilized women over time.
"The increase in dual use of condoms with sterilization is promising because increasingly more sexually active women, especially those at high risk for HIV infection, are using this contraceptive method to regulate fertility," they write.
More than one million tubal sterilizations are performed in the US each year, according to the report.
SOURCE: Sexually Transmitted Diseases 1998;25:335-341.
980820
RE980808
Copyright © 1998 - Reuters, Ltd. All rights reserved. Republication or redistribution of Reuters content is expressly prohibited without the prior written consent of Reuters. Reuters shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Contact Reuters.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 1998. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 1998. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .